MSK Pharmacology Flashcards
Inhibitor of dihydrofolate reductase
Methotrexate
Methotrexate inhibits this
Dihydrofolate reductase
This drug is slow in onset of benefit (>6 weeks) but can be very effective for a long time
Methotrexate
Most commonly used DMARD, alone or in combination with biologics
Methotrexate
Methotrexate has bone marrow toxicity when coadministered with these
NSAIDs
Methotrexate is contraindicated in these 2 circumstances
Pregnancy and Renal failure
Methotrexate has drug interactions with these
Protein binding drugs
This DMARD has interactions with protein binding drugs
Methotrexate
This DMARD has bone marrow toxicity when coadministered with NSAIDs
Methotrexate
Drug that blocks pyrimidine synthesis by inhibiting dihydroorotate dehydrogenase
Leflunomide
Leflunomide blocks this by inhibiting dihydroorotate dehydrogenase
Pyrimidine synthesis
Leflunomide blocks pyrimidine synthesis by inhibiting this
Dihydroorotate dehydrogenase
Leflunomide has this black box warning
Hepatotoxicity
Leflunomide is contraindicated in this
Prengnancy (teratogenicity)
These two DMARDs together are super additive in benefit and toxicity (especially hepatotoxicity)
Methotrexate and Leflunomide
This may bind DNA and disrupt rheumatoid factor synthesis
Hydroxychloroquine
2 non-biologic DMARDs that can cause hemolysis in patients with deficiency in glucose-6-phosphate dehydrogenase
Hydroxychloroquine and Sulfasalazine
Hydroxychloroquine may bind DNA and disrupt synthesis of this
Rheumatoid factor
DMARD with unclear mechanism in Rheumatoid Arthritis, and hemolysis in patients with G6PD deficiency
Sulfasalazine
3 TNF inhibitors
Etanercept
Infliximab
Adalimumab
Recombinant human TNF receptor 2/IgG1 fusion protein (non-functional receptor fragment), acts as decoy receptor, captures TNF to block inflammation and decrease cytokine release
Etanercept
Biologic DMARD that acts as decoy receptor, captures TNF to block inflammation and decrease cytokine release
Etanercept
What is Etanercept?
Recombinant human TNF receptor 2/IgG1 fusion protein
Acts as a decoy receptor to capture TNF
Etanercept has increased risk of these 2 things
Malignancy and infections
DMARD that targets TNF alpha, suppresses cytokine synthesis and release
Infliximab
Drug with increased risk of infections and TB reactivation
Increased risk of lymphoma in children/adolescents
Infliximab
Infliximab has increased risk of infections, specifically reactivation of this
TB
Infliximab has increased risk of this in children/adolescents
Lymphoma
Recombinant human monoclonal antibody for TNF alpha, blocks interaction with receptor
Adalimumab
Oral Janus Kinase inhibitor (competitive)
Blocks intracellular Janus Kinase (JAK1 & JAK3) signal to disrupt activation of immune system
Tofacitinib
What does Tofacitinib do?
Blocks intracellular JAK signal to disrupt activation of immune system
(competitive oral janus kinase inhibitor)
Rheumatoid arthritis treatment usually begins with this monotherapy
Methotrexate
First line treatment for osteoarthritis
Acetaminophen
Treatment for moderate to severe osteoarthritis
NSAIDs, approved topical diclofenac gel available
These injections provide short-term (4-8 weeks) releif for osteoarthritis
Intra-articular glucocorticoid
Procedure that may be done to treat osteoarthritis
Autologous chondrocyte implantation
Autologous chondrocyte implantation can be therapy for this condition
Osteoarthritis
This is the end product of purine degradation in humans
Urate
Urate is the end product of this process in humans
Purine degradation
Tumor lysis syndrome/chemo-induced cell death can cause gout through this
Overproduction of uric acid
Is Colchicine used for acute or long-term gouty arthritis?
Acute
Are non-steroidal anti-inflammatory drugs used for acute or long-term gouty arthritis?
Acute
Are glucocorticoids used for acute or long-term gouty arthritis?
Acute
How is acute gouty arthritis treated?
Termination of inflammatory process
(colchicine, NSAID, glucocorticoids)
Is allopurinol and febuxostat used for acute or long-term gouty arthritis?
Long-term
Inhibit uric acid synthesis
Is probenecid and sulfinpyrazone used for acute or long-term gouty arthritis?
Long-term
Increase excretion
How is long-term gouty arthritis treated?
By decreasing uric acid production or increasing excretion
2 xanthine oxidase inhibitors
Allopurinol and Febuxostat
2 uricosuric agents
Probenecid and Lesinurad
Serum uric acid reduction may mobilize urate from tissue deposits, causing this
ULT-induced gouty flare
(urate lowering therapy)
Drug that binds tubulin, disrupts leukocyte recruitment to affected joints and inhibits leukotriene synthesis/release
Colchicine
Colchicine binds this, as it is an antimitotic
Tubulin
Colchicine disrupts recruitment of this to affected joints
Leukocytes
Colchicine inhibits synthesis/release of this
Leukotriene
Risk of bone marrow toxicity often limits therapy of acute attack with this drug to 7 days or less
Colchicine
Treatment for gout that may cause severe diarrhea and bone marrow toxicity
Colchicine
Allopurinol and Febuxostat inhibit this
Xanthine oxidase
Drugs that are indicated for multiple acute gout attacks per year, and tophi or chronic arthritis on exam
Allopurinol and Febuxostat
Allele that is strongly associated with Allopurinol hypersensitivity
HLA-B*5801
HLA-B*5801 allele is strongly associated with hypersensitivity to this
Allopurinol
Allopurinol should not be used with either of these 2 drugs, which are metabolized by xanthine oxidase
Mercaptopurine or azathioprine
Mercaptopurine and azathioprine should not be used with this drug
Allopurinol
Why should mercaptopurine and azathioprine not be used with allopurinol?
Both are metabolized by xanthine oxidase, which allopurinol inhibits
Dose should be reduced to 1/4 normal dose when combined with allopurinol
Drug that should not be given with allopurinol, because allopurinol inhibits CYP1A2
Theophylline
Theophylline is metabolized by this, which allopurinol inhibits
CYP1A2
Allopurinol inhibits CYP1A2, blocking metabolism of this
Theophylline
Probenecid and Sulfinpyrazone block this
Urate reabsorption
Two drugs that block urate reabsorption
Probenecid and Sulfinpyrazone
Drug that blocks urate reabsorption and impacts PK of some drugs
Probenecid
Common adverse effects of this drug include gouty arthritis and stone formation
Probenecid
An adverse effect of Probenecid is formation of this
Stone
An adverse effect of Probenecid is that it can induce this
Gouty arthritis
Severe adverse effects of this drug include bone marrow depression and hypersensitivity
Probenecid
Probenecid is contraindicated in cases of this
Renal impairment/calculi
Probenecid interacts with this type of drug
Anti-uricosuric drugs (salicylates, diclofenac, pyrazinamide)
Probenecid increases serum levels of this drug
Methotrexate
Drug that increases serum methotrexate
Probenecid
Drug that interacts with anti-uricosuric drugs (salicylates, diclofenac, pyrazinamide, et al)
Probenecid
Drug for gout that has a high risk of anaphylaxis (clinical setting - given only after premedication with antihistamines and corticosteroids)
Pegloticase
Black box warning of Pegloticase
High risk of anaphylaxis
Colchicine is used to treat this condition
Gout